ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

Fruits, Vegetables Protective Against Cancer, IARC Says

May 30, 2003

AACR 2014 Cancer Progress Report: More Federal Funds Needed

September 19, 2014

Judge Rules Privacy Act Not Applicable In Bernard Fisher’s Suit Against HHA

July 5, 1996

Obama’s First Budget Proposes $6 Billion For Cancer Research As Step To Doubling

February 27, 2009

NCAB Committee Still Debating How To Encourage Surgical Oncology

April 26, 1985

NCI Bypass Budget For FY99 Proposes Expansion of Cancer Clinical Trials System

December 5, 1997